Anti-USP39 antibody [EPR8683]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(19 Publications)
Rabbit Recombinant Monoclonal USP39 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 19 publications.
View Alternative Names
CGI-21, HSPC332, PRO2855, USP39, Ubiquitin carboxyl-terminal hydrolase 39, SAD1 homolog, U4/U6.U5 tri-snRNP-associated 65 kDa protein
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP39 antibody [EPR8683] (AB131244)
Immunohistochemical analysis of paraffin-embedded Human colonic adenocarcinoma tissue labelling USP39 with ab131244 at 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-USP39 antibody [EPR8683] (AB131244)
Immunofluorescence analysis of HeLa cells labelling USP39 with ab131244 at 1/100 dilution.
- WB
Unknown
Western blot - Anti-USP39 antibody [EPR8683] (AB131244)
All lanes:
Western blot - Anti-USP39 antibody [EPR8683] (ab131244) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Lane 3:
K562 cell lysate at 10 µg
Lane 4:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 65 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-USP39 antibody [EPR8683] (AB131244)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-USP39 antibody [EPR8683] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
USP39 plays a significant role in pre-mRNA splicing a process critical for the maturation of messenger RNA. It forms part of the U4/U6.U5 tri-snRNP complex which is essential for spliceosome assembly. This protein ensures proper spliceosome cycling by stabilizing snRNPs contributing to the accurate removal of introns from pre-mRNA sequences. Its involvement in RNA processing highlights its importance in gene expression regulation.
Pathways
USP39 integrates into the spliceosome pathway and is also linked to the mRNA surveillance pathway. These pathways are important for correct mRNA synthesis and degradation. USP39 functions alongside other splicing factors such as PRPF8 and EFTUD2 which are important components of the spliceosome machinery. By working synchronously with these proteins it maintains efficient RNA processing and cellular homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (19)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 16:564 PubMed40715045
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology international 49:1003-1014 PubMed40405439
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 21:807 PubMed37957720
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:7032 PubMed37923718
2023
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 34:101713 PubMed37302347
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:63 PubMed36707504
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of hematology & oncology 15:112 PubMed35978332
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:858901 PubMed35600879
2022
Applications
Unspecified application
Species
Unspecified reactive species
Genes 13: PubMed35627203
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular oncology 16:388-404 PubMed33811456
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com